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We describe here the cloning of a new member of the TGF-β family with similarity to the anti-dorsalizing morphogenetic proteins (ADMPs).
This new gene, ADMP2, is expressed in a broad band of mesendoderm cells that appear to include the progenitors of the endoderm and the ventral
mesoderm. Antisense morpholino oligonucleotide knockdown of ADMP2 results in near-complete disruption of primitive blood and heart
development, while the development of other mesoderm derivatives, including pronephros, muscle and lateral plate is not disrupted. Moreover, the
development of the primitive blood in ADMP2 knockdown embryos cannot be rescued by BMP. These results suggests that ADMP2 plays an
early role in specifying presumptive ventral mesoderm in the leading edge mesoderm, and that ADMP2 activity may be necessary to respond to
BMP signaling in the context of ventral mesoderm induction.
© 2006 Elsevier Inc. All rights reserved.Keywords: Xenopus; Mesoderm; BloodIntroduction
Xenopus laevis has long served as a model for vertebrate
mesoderm patterning. Multiple determinative and inductive
mechanisms are responsible for patterning the mesoderm along
the dorsal/ventral, anterior/posterior and left/right axes. Dorso-
ventral patterning is evident in the larval trunk, with notochord
situated at the dorsal midline, somites located ventral and lateral
to the notochord, followed by pronephros and lateral plate, and
finally, the blood islands occupying the ventral-most region.
Models have attempted to explain dorsoventral mesoderm
patterning in Xenopus through the action of the Spemann
organizer. Most simply, it was proposed that a gradient of
induction arising from the Spemann organizer would specify
mesodermal identities due to the relative positions of the
presumptive mesodermal cells in the gastrula marginal zone
(Kessler and Melton, 1994; Harland and Gerhart, 1997;
Heasman, 1997; Dale and Jones, 1999; Dale and Wardle,
1999; De Robertis et al., 2000; De Robertis and Kuroda, 2004).
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doi:10.1016/j.ydbio.2006.08.010specified to dorsal fates such as somite, while those cells
furthest away from the Spemann organizer would be specified
as ventral, such as blood island.
Despite a wealth of data consistent with the Spemann
organizer model of dorsoventral pattern, recent studies have
raised questions regarding this model (Lane et al., 2004;
Kumano and Smith, 2002b). First, the mesoderm precursors
are not distributed in a simple dorsal to ventral array with respect
to the Spemann organizer in the gastrula embryo. The posterior
somites, for example, are derived from mesoderm that is at the
opposite side of the marginal zone from the Spemann organizer
(the contra-organizer marginal zone) (Dale and Slack, 1987;
Moody, 1987; Lane and Smith, 1999), while anterior blood
islands are derived from mesoderm that is immediately adjacent
to the Spemann organizer (Tracey et al., 1998; Lane and Smith,
1999; Mills et al., 1999; Ciau-Uitz et al., 2000). Second, a great
deal of patterning of themarginal zone is observed in the absence
of the Spemann organizer, including the restriction of the blood
islands to the presumptive ventral mesoderm (Kumano and
Smith, 2000), and the restriction of myoD expression to a
domain in the early gastrula embryo that appears to correspond
to the presumptive somites (Kumano and Smith, 2002b).
These difficulties with the Spemann organizer model of
mesoderm patterning have led to a hunt for alternative models
(Kumano and Smith, 2002b). One key early activity for
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be FGF. Experimental reduction of FGF activity with a dominant
negative FGF-receptor results in expansion of the blood islands
with a corresponding loss of somites (Kumano and Smith,
2000). We have shown that manipulation of FGF signaling alters
the response of Xenopus animal cap ectoderm explants (animal
caps) to the mesoderm inducer nodal in a way that appears to
mirror induction in the gastrula marginal zone (Kumano et al.,
2001). Whereas exogenous Xenopus nodal related-2 (Xnr2)
alone induces dorsal mesoderm (skeletal muscle) in animal caps,
inhibition of endogenous FGF signaling in the animal cap with a
dominant negative FGF receptor (XFD) results in the induction
of ventral mesoderm (primitive blood) in response to exogenous
Xnr2. It has been described previously that animal caps have
elevated FGF signaling due to the injury caused by dissection
(LaBonne and Whitman, 1997; Christen and Slack, 1999). The
animal cap thus represents a highly tractable model for
investigating the mechanisms that pattern mesoderm in the
gastrula embryo. We report here results from a subtraction
cloning project aimed at identifying genes that are induced in
animal caps by Xnr2 in the absence of FGF signaling. We
describe the identification of a new member of the transforming
growth factor-β (TGF-β) family, Xenopus anti-dorsalizing
morphogenetic protein 2 (ADMP2). ADMP2 is expressed
endogenously at gastrulation in a broad band of cells that
appears to include the endoderm and the leading edge
mesoderm. Antisense morpholino oligonucleotide knockdown
of ADMP2 resulted in disruption of the development of the
blood islands and heart, both ventral mesoderm derivatives, but
had no apparent effect on the development of other mesoderm
derivatives such as somite and lateral plate.
Materials and methods
Xenopus embryos
Ovulation was induced by injecting female X. laevis with human chorionic
gonadotropin (Sigma) and eggs were fertilized as described previously (Condie
and Harland, 1987). Eggs were dejellied 20 min after fertilization in 2%
cysteine–HCL (pH 8.0), and were cultured in 1/3 MMR until ready for injection
and RNA extraction. Embryos were staged according to Nieuwkoop and Faber
(1994).
Isolation of Xenopus ADMP2 by subtraction and 5′ RACE
ADMP2 was identified by nucleotide sequencing of randomly picked clones
from a previously described subtracted library (Kumano and Smith, 2002a). A
full-length cDNA was isolated by 5′ RACE using the SMART RACE cDNA
Amplification Kit (CLONTECH) and the oligonucleotide (5′-ATGGCACCCA-
CAGCTGACAGCAATCA-3′) as a gene-specific primer.
Plasmid constructs, RNA synthesis and microinjection
In vitro transcription constructs for microinjection in the vector pSP64T3
(Thomsen andMelton, 1993) were prepared as follows. For ADMP2, a fragment
containing the 5′ UTR, the entire coding region and a partial 3′ UTR of ADMP2
was PCR-amplified with the upstream oligonucleotide (5′-GTACGGTACCA-
TAGATGACACTTGACCAACCACTGGGAAAGTT-3′), which added a KpnI
site at the 5′ end, and the downstream oligonucleotide (5′-CAACAAGGATCCT-
GACCAGGCAGGTATATAGA-3′), which added aBamHI site at the 5′ end. The
fragment was then digested with KpnI/BamHI and subcloned into the KpnI andBglII sites of pSP64T3. An ADMP construct was made using the same strategy
with the exception that the upstream KpnI-containing oligonucleotide (5′-
CACAAGGTACCTCGAGAGCTGCAGCTTGATGAGATGGA-3′) and the
downstream BglII-containing oligonucleotide (5′-TCTATAGATCTCCC-
TAGTTTGCACCTTAGACAGTACCACCA-3′) were used, and that the
amplified fragment was digested with KpnI/BglII.
A GFP-tagged version of ADMP2 (A-GFP) was made to test the activity
of the morpholino oligonucleotide. For this construct, a fragment containing
the 5′ UTR and the first 6 nucleotides of the coding region of ADMP2 was
PCR-amplified using the KpnI-containing oligonucleotide described above
and 5′-AATAGAGCTCGCACATCCTTGCTTCTTGGGTGAAAGTTGCCT-
3′, which added a SacI site at the 5′ end. The fragment was then digested
with KpnI/SacI. A GFP cDNA in pSP64T3 was prepared by excising the
Xmenf cDNA from previously described GFP-tagged version of Xmenf
(Kumano and Smith, 2002a) by KpnI/SacI digestion. The KpnI/SacI digested
ADMP2 fragment was then ligated into the KpnI and SacI sites of the GFP-
containing vector. The resulting construct has additional Glu-Leu residues
inserted between the ADMP2 and GFP coding regions.
An ADMP2 construct in which the entire 5′ UTR is deleted (ADMP2 Δ-5′
UTR) was made for morpholino oligonucleotide rescue experiments. A fragment
that contained the entire coding region and a partial 3′ UTR of ADMP2 but not
the 5′ UTR was PCR-amplified using the oligonucleotide (5′-AGAAGGTAC-
CATGTGCTTGGCGTATTTCTGCTTTCTGATGCT-3′), which added a KpnI
site at the 5′ end and the BamHI-containing oligonucleotide described above.
The amplified fragment was digested withKpnI/BamHI and ligated into theKpnI
and BglII sites of pSP64T3.
Plasmids for in vitro RNA synthesis were linearized with EcoRI for XFD
(Amaya et al., 1991), bFGF (Kimelman andMaas, 1992), tBR (Suzuki et al., 1994),
ADMP andADMP2,withXhoI for Xnr2 andBMP7 (Nishimatsu et al., 1992), with
BamHI for Xwnt8 (Christian et al., 1991), and with SalI for A-GFP and ADMP2
Δ-5′UTR. Capped RNAs were transcribed with mMessage mMachine (Ambion).
Embryos were injected by air pressure in 1/3× MMR, 2.5% ficoll and 25 μg/ml
gentamycin. For animal cap assays, 10 nl containing 200 pg of XFD, 500 pg of
Xnr2 or 200 pg of XFD plus 500 pg of Xnr2 RNAs was injected into the animal
regions of the both blastomeres at the two-cell stage. 250 pg of ADMP, ADMP2 or
BMP7 RNAs was injected with or without 500 pg of tBR RNA into the animal
regions of the both blastomeres at the two-cell stage. Also, 100 pg of Xwnt8 RNA
was injected into the same regions. Finally, 1 nl containing 200 pg of XFD RNA
was injected into both theAB4 (themother cell ofA4 andB4) andCD4 (themother
cell of C4 and D4) blastomeres at the 16-cell stage.
RNA extraction and Northern blot
Total RNA was isolated from whole embryos and animal caps using Trizol
Reagent. Northern analysis was performed as described previously (Kumano et
al., 2001). Probes were prepared with isolated fragments from alpha T3 globin
(Banville and Williams, 1985), muscle actin (Dworkin-Rastl et al., 1986) and
EF1α (Krieg et al., 1989). A probe for ADMP was prepared by digesting the
ADMP in vitro transcription construct withKpnI/BglII. A probe for ADMP2was
prepared by digesting a pCRII plasmid containing the ADMP2 5′RACE product
with EcoRI.
In situ hybridization
Detection of ADMP2, XmyoD (Hopwood et al., 1989), Xlim1 (Taira et al.,
1994), Xnr1 (Lustig et al., 1996), endodermin (edd, Sasai et al., 1996), αT3
globin (Banville andWilliams, 1985), SCL (Mead et al., 1998),Nkx2.5 (Tonissen
et al., 1994) and TnIc (Drysdale et al., 1994) expression by in situ hybridization
was performed as described previously (Moos et al., 1995). A digoxigenein-
labeled probe for ADMP2 was synthesized with T7 polymerase using the
plasmid that contains the ADMP2 5′ RACE product and that was linearized with
BamHI.
Morpholino knockdown and Western blotting
The morpholino oligonucleotide used to knockdown ADMP2 expression,
A-MO (5′-CACATCCTTGCTTCTTGGGTGAAAG-3′), was purchased from
413G. Kumano et al. / Developmental Biology 299 (2006) 411–423Gene-Tools LLC. The standard control (c-MO) provided by Gene-Tools was
used as a negative control. c-MO or A-MO (5 or 10 ng) was injected into the
marginal zone of either the anterior (lighter pigmentation) or posterior (darker
pigmentation) two blastomeres at the 4-cell stage. To test the efficacy of the
morpholino knock-down approach, embryos were separately injected at the
animal pole with 10 ng of either c-MO or A-MO and 100 pg of A-GFP RNA.
The injected embryos were cultured to the neurula stage at which point protein
was extracted using the freon method to remove yolk from the lysates (Gurdon
and Wickens, 1983). The proteins were resolved by 12% SDS-PAGE,
transferred to nitrocellulose membrane Hybond ECL (Amersham) and blocked
for 2 h at room temperature with 2% nonfat milk in 20 mM Tris–HCl pH 7.4,
150 mM NaCl and 0.1% Tween 20. Immunoblotting was performed using the
chemiluminescence method (PIERCE). Anti-GFP (Santa Cruz) and anti-alpha-
tubulin antibodies (Sigma) were used at a dilution of 1:500.
For the rescue experiments, 10 ng of A-MO, with or without 10 pg of
ADMP2Δ–5′ UTR RNA, was injected into the marginal zone of the posterior 2
blastomeres at the 4-cell stage, and 10 ng of A-MO with or without 5 pg of
ADMP2 Δ-5′ UTR RNAwas injected into the marginal zone of the anterior 2
blastomeres at the 4 cell stage. ADMP2Δ-5′ UTR has 15 mismatches out of the
25 nucleotides for the morpholino oligo.
Finally, 250 pg of BMP7 RNA (total 1 ng) with or without 10 ng of A-MO
(total 40 ng) was injected into the marginal zone of all the blastomeres at the 4-
cell stage.
β-galactosidase staining
10 ng of A-MO was injected into the posterior 2 blastomeres (total 20 ng) at
the 4-cell stage, and subsequently, 250 pg of βgal RNA was injected into both
the A4 and B4 blastomeres (total 1 ng) of the A-MO-injected embryos at the 32-
cell stage. The twice-injected embryos were cultured until stage 32 and
subjected to βgal staining followed by globin in situ hybridization. βgal staining
was done as described previously (Kumano et al., 1999).
Phylogenic analysis
The sequences of fugu ADMPs (FrADMP) were obtained from: http://fugu.
hgmp.mrc.ac.uk. The sequences of Xenopus tropicalis ADMPs (XtADMP) were
obtained from: http://genome.jgi-psf.org/xenopus0/xenopus0.home.html. The
sequence of Ciona intestinalis ADMP (CiADMP; Hino et al., 2003) was
obtained by searching Ghost Database: a C. intestinalis cDNA resource at http://
ghost.zool.kyoto-u.ac.jp/indexr1.html. For those genes in GenBank, the
accession numbers are as follows: XlADMP, U22155; chick ADMP (GgADMP),
AF082178; zebrafishADMP (DrADMP),AJ315468/AF418564/NM131876; rat
BMP3 (RnBMP3), D63860/NM017105/S77492; XlBMP7, X63427/U38559;
XlBMP2, X63424/X63425/X55031; XlBMP4, X63426/X64538. Amino acid
sequences were aligned using CLUSTAL X and then the phylogenetic tree was
generated by the neighbor-joining method.
Results
ADMP2 is a novel member of the TGF-β superfamily
To identify genes potentially involved in ventral mesoderm
induction, a subtractive cloning approach was used to isolate
genes that were induced by Xnr2 in Xenopus animal caps in the
absence of FGF signaling (Kumano and Smith, 2002a). So far,
two novel genes have been isolated by this approach. The first of
the two, Xmenf, has been described previously (Kumano and
Smith, 2002a). The second gene, and the subject of this report, is
a novel member of the TGF-β family. This gene was identified
by sequencing the ends of 100 randomly selected subtracted
clones. The initial isolate of this gene was a partial cDNA clone
(297 bp) that showed strong sequence similarity to Xenopus,
chick and zebrafish anti-dorsalizing morphogenetic proteins(ADMPs) using a translated BLAST search (Moos et al., 1995;
Joubin and Stern, 1999; Lele et al., 2001), and was named
ADMP2. ADMP2 was found to be expressed more highly in
RNA samples from animal caps injected with Xnr2 and
dominant negative FGF receptor (XFD) RNAs versus those
injected with XFD RNA alone (data not shown). The partial
ADMP2 cDNA contained the stop codon and a partial 3′ UTR,
but neither the 5′UTR nor the translation start site. A full-length
ADMP2 cDNAwas subsequently obtained by 5′ RACE using a
primer in the 3′ UTR. The 1652 bp 5′ RACE product had a
306 bp 5′ UTR, a 1200 bp open reading frame and 146 bp of 3′
UTR. The deduced amino acid sequence had several features
characteristic of the TGF-β superfamily, including two con-
sensus RXXR proteolytic processing sites (Ozkaynak et al.,
1992) and seven highly conserved cysteine residues in a
carboxyl terminal domain at the positions observed in other
members of this family.
In nearly all TGF-βs, the C-terminal one-third of the protein
constitutes the mature processed form. Accordingly, database
searching and multiple pair-wise alignments of ADMP2 to other
ADMP-like and BMP molecules were performed using a C-
terminal domain following the first conserved cysteine residue,
which approximates the mature domain. Within this region,
ADMP2 showed 78.6%, 76.7% and 74.8% amino acid sequence
identities with Xenopus, chick and zebrafish ADMPs, respec-
tively. Xenopus ADMP, on the other hand, showed 94.2% and
82.5% identities with chick and zebrafish ADMPs, respectively.
From a BLAST search of the unassembled sequence traces from
the X. tropicalis genome sequencing project (http://genome.jgi-
psf.org/xenopus0/xenopus0.home.html), we identified two pre-
dicted genes that appeared to be the orthologs of X. laevis
ADMP and ADMP2. The predicted X. tropicalis and X. laevis
ADMP and ADMP2 proteins had 100% and 99% sequence
identity in the mature region, respectively. It is hypothesized that
X. laevis has undergone a genome duplication following its split
the lineage leading to X. tropicalis. The presence of ADMP and
ADMP2 orthologs in both Xenopus species rules out that the two
genes could be the product of the proposed genome duplication
in X. laevis. Outside of the two Xenopus species, two separate
predicted ADMP-like genes were identified in the Fugu rubripes
(http://fugu.hgmp.mrc.ac.uk) and Tetraodon nigroviridis (http://
www.genoscope.cns.fr/externe/tetraodon) genomes. However, a
search of the zebrafish genome and ESTs yielded only a single
ADMP gene. Fig. 1A shows an alignment between the mature
domain of ADMP2 and other similar TGF-β family members.
Phylogenetic analysis (Fig. 1B) is consistent with orthology
assignments made based on BLAST searches. Moreover, the
resulting tree topology supports two distinct groupings within
the ADMP-like molecules. The presence of two predicted
ADMPs in a teleost suggests that the duplication giving rise to
ADMP and ADMP2 preceded the split of the lineages leading to
tetrapods and fish.
The temporal and spatial expression of ADMP2 mRNA
Expression of ADMP2 was first detectable by Northern blot
analysis at late blastula stage (stage 9) and persisted through the
Fig. 1. The predicted ADMP2 protein. (A) Alignment of mature domain of Xenopus laevis ADMP2 (XlADMP2) with other members of the TGF-β family. (B) The
schematic representation of the relationship between XlADMP2 and members of the ADMP and BMP families. The number at each branch point represents the relative
incidence of that particular relationship during bootstrap resampling using 1000 replicates. The scale bar at the left bottom indicates an evolutionary distance of 0.1
amino acid substitution per position.
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expression of ADMP2 was examined by in situ hybridization
from early to late gastrula (stages 10 to 12; Nieuwkoop and
Faber, 1994). At all stages, the hybridization signal for ADMP2
was very weak, and was best visualized in embryos that had been
sectioned prior to hybridization. At stage 10 (Fig. 2B), a sagittal
section shows strongest hybridization in a wedge of cells on the
contra-organizer side (Kumano and Smith, 2002b) extending
from surface of the marginal zone and narrowing towards the
floor of the blastocoel. The surface marginal zone staining
appears to correspond to a region that we have previously
labeled as the “vegetal marginal zone,” and which is found
immediately vegetal to the band of Brachyury (Xbra) expression
(Kumano and Smith, 2000). To investigate this further, stage
10.5 embryos were split along the organizer/contra-organizer
axis into right an left halves. Figs. 2C andD show two halves of a
single embryo, one half of which was hybridized for ADMP2
(Fig. 2C), and the other for Xbra (Fig. 2D). In comparing the two
halves, it can be seen that the expression domains of Xbra andADMP2 are very different, and apparently exclusive of each
other. Significantly, the expression domain of ADMP2 extends
below (i.e., vegetally) that of Xbra, and then extends upwards
(i.e., animally) towards the blastocoel floor in cells that lie
deeper than those expressing Xbra. The precise fate and germ
layer origin of the ADMP2-expressing cells in the early gastrula
are unclear. However, analysis of cell movements and fates in
this region of the gastrula shows that mesoderm derives not only
from the marginal zone, but also from the blastocoel roof
(Ibrahim and Winklbauer, 2001). These authors describe ventral
mesoderm as being derived from a similarly shaped wedge of
tissue at stage 10.5, with the cells at the blastocoel floor
comprising the leading edge (see: Fig. 10, Ibrahim and
Winklbauer, 2001). However, the expression domain of
ADMP2 is broader (i.e., deeper) than this, and includes
endodermal cells. In the absence of the molecular probes
required to precisely map the fates of ADMP2-expressing cells,
the ADMP2 expression domain might best be referred to as
mesendoderm.
Fig. 2. Expression of ADMP2. (A) Expression of ADMP2 by Northern blotting of RNA from staged Xenopus embryos. Expression was first seen at stage 9 and
persisted through the early neurula stage. Ethidium staining for 28S and 18S RNAs serves as a loading control. (B) In situ hybridization for ADMP2 in stage 10 embryo
bisected sagittally. Arrows indicate general region of specific hybridization. (C and D) Two halves of bisected stage 10.5 embryo hybridized with either ADMP2 (C),
or brachyury (D) (for the benefit of comparison, one image is inverted). (E and F) Sagittal (E) and para-sagittal (F) sections of stage 11 embryos hybridized for
ADMP2. (G) Vegetal view of schematic stage 11 embryo indicating the approximate lines of bisection of embryos in panels E and F. (H and I) Stage 12 embryos
hybridized for ADMP2. Dorsal is up and ventral is down for both embryos. Panel H shows sagittal section, while panel I shows transverse section. (J) Schematic view
of stage 12 embryo showing the approximate plans of view in panels H and I. S.O.: approximate position of the Spemann organizer. bc: position of the blastocel.
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contra-organizer side of the embryo, but positively staining cells
can be seen extending towards, but not including, the Spemann
organizer. Consistent with this, all expression of ADMP2 was
abolished by injection of Xwnt8 RNA, which results in
expansion of the Spemann organizer (Smith and Harland,
1991; Sokol et al., 1991) (not shown). The lateral extent of
ADMP2 expression towards the Spemann organizer increases
during gastrulation, and could be best visualized at stage 11 in
sagittal (Fig. 2E) and para-sagittal (Fig. 2F) sections (see Fig. 2G
for diagram of sections). In the sagittal section (i.e., running
through the Spemann organizer), hybridization could only be
detected on the contra-organizer side. However, in the para-
sagittal section, hybridization on the Spemann organizer side of
the embryo largely mirrored that seen on the contra-organizer
side, with ADMP2 expressing cells found in deeper layers, and
extending towards the blastocoel floor.
At late gastrulation (stage 12), the expression of ADMP2 in
presumptive ventral mesendoderm is evident both in sagittal and
transverse sections. During gastrulation, the leading edges of the
involuting mass of cells converge at the ventral midline as theymigrate along the walls and roof of the blastocoel (Keller, 1991).
In the sagittal (Fig. 2H) section (see Fig. 2J for diagram of
sections), ADMP2 can be detected in cells surrounding the
collapsed blastocoel. Comparison of the ADMP2 staining
pattern to fate maps of cells in this region, indicates that
ADMP2 is expressed in both presumptive ventro-lateral
mesoderm and endoderm. In an anterior transverse section that
passes through the blastocoel (Fig. 2I), hybridization was
detected in two “wings” of mesendoderm extending towards the
ventral midline. No hybridization was detected in dorsal
mesoderm, nor in endodermal cells making up the archenteron
floor and roof.
ADMP2 regulation in animal caps and whole embryos
The basis for isolating ADMP2 was its induction in animal
caps by Xnr2 in the absence of FGF signaling. To determine if
FGF signaling plays a role in the regulation of ADMP2,
animal caps were injected with Xnr2 RNA either with or
without XFD RNA. We observed a much stronger induction of
ADMP2 by the combination of Xnr2 and XFD compared to
Fig. 3. Regulation of ADMP2 expression in animal caps and whole embryos.
Northern blot of RNA from stage 10.5 animal caps injected with 1 ng of Xnr2
with or without 400 pg of XFD RNAs. The figure shows the results of
hybridizations for ADMP2, ADMP and EF1α (loading control). Xnr2 RNA
alone induces a low level of ADMP2 expression in animal caps, while
co-injection of XFD RNA causes a much higher level of ADMP2 expression.
ADMP expression, on the other hand, was inhibited by XFD.
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FGF contrasted with the expression of ADMP, which was
induced strongly in animal caps by Xnr2 alone, but not at all
by the combination of Xnr2 and XFD (Fig. 3). Thus, ADMP
appears to be regulated similarly to Xbra and myoD, both of
which are positively regulated by FGF (Hopwood et al., 1989;
Smith et al., 1991; Cornell and Kimelman, 1994; LaBonne and
Whitman, 1994; Kumano et al., 2001). In whole embryos,
ADMP2 expression was also observed to be regulated by FGF
signaling. Injection of XFD RNA resulted in increased
ADMP2 expression, while injection of Xnr2 RNA alone had
relatively little effect on ADMP2 expression. The induction of
ADMP2 expression by Xnr2 in animal caps but not whole
embryos may simply reflect de novo mesoderm induction in
the former.
We have speculated that high levels of FGF signaling
characterize presumptive dorsal mesoderm in the gastrula
embryo, such as is found in the cells that express myoD and
Xbra (Kumano and Smith, 2002b). Consistent with this, ADMP
is expressed at stage 11 in late-involuted mesoderm cells in the
Spemann organizer region (Moos et al., 1995), and at stage 13 in
chordamesoderm (Dosch and Niehrs, 2000). The regulation of
ADMP2, on the other hand, is more similar to that of genes Xnr2
and Xmenf, which are induced most strongly in animal caps by
nodal and activin when FGF signaling is inhibited (Kumano and
Smith, 2002a).
ADMP2 has a BMP-like activity
The phenotypes produced by injecting Xenopus embryos
with high doses of RNA encoding either ADMP or ADMP2
are indistinguishable (Moos et al., 1995; Figs. 4D and E), and
are characterized by an absence of head and dorsal structures
such as somite, and a failure to elongate. This corresponds to a
0 in the DAI scale (Kao and Elinson, 1988) and is equivalent to
the phenotype of BMP overexpression. Consistent with the
DAI zero phenotypes, we observed that embryos which hadbeen injected with BMP7, ADMP or ADMP2 had elevated
globin expression but no muscle actin expression (Fig. 4A,
lanes 2, 4 and 6 compared to lane 1). Although globin
expression in the ADMP2-injected embryos was increased in
amount, it was still restricted to the leading edge mesoderm
(Fig. 4B, white arrow heads), similar to what is observed in UV-
irradiated, BMP-injected and dnTcf3-injected embryos (Cooke
and Smith, 1987; Kumano and Smith, 2000). The BMPs that
give similar DAI zero phenotypes (BMP2, 4 and 7) all bind the
type I BMP receptors (BMP2 and 4 bind to ALK3 and 6, and
BMP7 binds to ALK2, 3 and 6; Graff et al., 1994; Suzuki et al.,
1994; ten Dijke et al., 1994; Koenig et al., 1994). Based on the
observation that a truncated ALK3 BMP receptor (tBR) was
able to reverse the effects of BMP over expression, but not those
of ADMP overexpression, it was proposed that ADMP does not
act through the ALK3 BMP receptor (Dosch and Niehrs, 2000).
In fact, recent results show that ADMP binds to the ALK2
receptor, but not ALK3 nor 6 (Reversade and De Robertis,
2005). Similarly to the observation by Dosch and Niehrs (2000),
we observed that the co-injection of tBR did not dramatically
change the phenotypes caused by ADMP2 overexpression
(Figs. 4H and I compared to Figs. 4D and E, respectively).
Moreover, co-injection of tBR restored muscle actin expression
to the level of control embryos only in embryos that had been
injected with BMP7 but not with ADMP or ADMP2 (Fig. 4A,
lanes 3, 5 and 7 compared to lane 1). Some rescue ofmuscle actin
was observed by co-injection of tBR in the ADMP2-injected
embryos, and this may reflect some binding of ADMP2 to the
BMP receptor which may result from overexpression. Globin
expression, on the other hand, was eliminated by co-injection of
tBR in all cases (Fig. 4A, lanes 3, 5 and 7 compared to lane 1),
consistent with the fact that BMP signaling is essential for blood
formation (Dale et al., 1992; Jones et al., 1992; Graff et al.,
1994; Maeno et al., 1994a). In summary, ADMP2 does not
appear to act mainly through the ALK3 receptor, and like
ADMP may act through the ALK2 receptor.
Antisense morpholino “knockdown” of ADMP2
In order to study the role of ADMP2 during Xenopus
embryogenesis, we generated an antisense morpholino oligo-
nucleotide against ADMP2 (A-MO) for gene knockdown
analysis (Heasman et al., 2000). In initial experiments, the
efficiency of the A-MO in inhibiting translation of ADMP2 was
tested using a green fluorescent protein (GFP)-tagged version of
ADMP2 (A-GFP) in which the GFP coding region was added to
a partial ADMP2 cDNA composed of the entire 5′ UTR and the
first 6 nucleotides of the coding region. The A-MO spans
nucleotides +5 to −20 with respect to the ATG of ADMP2. An
in vitro synthesized A-GFP RNA was injected into both
blastomeres of two-cell stage embryos that had previously been
injected with either A-MO or a control morpholino oligonu-
cleotide (c-MO). Proteins were extracted from the injected
embryos at the neurula stage, and Western blot analysis with an
anti-GFP antibody showed that translation of A-GFP was
decreased in the embryos that had been injected with A-MO
when compared to c-MO-injected embryos (Fig. 5).
Fig. 4. Overexpression of ADMP2. (A) Northern blot of RNA from stage 32 sibling embryos of the ones shown in panels C–F and H–J. The figure shows the results of
hybridizations for globin, muscle actin (m.actin) and EF1α (loading control). The expression of globin was increased by overexpression of ADMP2, ADMP or BMP7
RNA (lanes 2, 4 and 6 compared to lane 1), while that of m.actin was virtually eliminated by the same treatment (lane 2, 4 and 6 compared to lane 1). The level of
m.actin expression in the BMP7-injected embryos was rescued to normal levels by co-injection of tBR RNA (lane 7 compared to lane 1). However, in the ADMP2 or
ADMP-injected embryos, co-injection of tBR RNA failed to rescue m.actin expression (lanes 3 and 5 compared to lane 1). (B) The phenotype and globin expression by
in situ hybridization in ADMP2-overexpressed embryos. The expression of a blood marker, globin, is normally detectable in the ventral-most region of the tailbud
stage embryo at stage 32 (white arrowheads in top embryo). Overexpression of ADMP2 caused a typical DAI 0 phenotype (two bottom embryos). The expression of
globin was restricted in the leading edge mesoderm of these embryos (white arrowheads) at the equivalent of stage 32. (C–J) Rescue experiments by co-injection of
tBR RNA. Overexpression of either ADMP2, ADMP or BMP7 RNA caused a similar DAI 0 phenotype (C–E compared to B). However, only the phenotype caused by
overexpression of BMP7 was rescued by co-injection of tBR RNA (G–I), suggesting that ADMP2 and ADMP do not bind the BMP receptor. (G) The phenotype of
tBR RNA-injected embryos. All the embryos shown are at stage 32.
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We next examined the effect of A-MO on Xenopus
embryonic development. Morpholino oligonucleotide injections
were performed at the 4-cell stage into two blastomeres on either
the Spemann organizer side or the contra-organizer side. The A-
MO and c-MO-injected embryos were analyzed by in situ
hybridization for genes expressed in dorsal mesoderm (myoD),
lateral mesoderm (Xnr1 and Xlim1), ventral mesoderm [globin
and SCL (blood); Nkx2.5 and cardiac troponin I (TnIC) (heart)]
and endoderm (endodermin) (Table 1). The A-MO-injected
embryos at both doses tested (5 and 10 ng/blastomere) appeared
largely normal, and had no gross malformations, such as axial
defects. Furthermore, the expression of myoD, Xlim1, Xnr1
and endodermin in embryos injected with 10 ng/blastomere of
A-MO was indistinguishable from control embryos (Figs. 5B
through G, Figs. 7L and M). Because the A-MO does not
create a null – rather it “knocks down” the gene product – we
cannot conclude that ADMP2 plays no role in the development
of these tissues.
However, further analysis of these embryos by in situ
hybridization revealed that 97% of the embryos (n=30) injected
anteriorly with 10 ng/blastomere A-MO had greatly reduced
expression of the heart marker, Nkx2.5, and 93% of the
embryos (n=29) injected posteriorly had a strong reduction inexpression of the blood marker globin in the posterior ventral
blood islands (VBIs) (Table 1). The range of reduction observed
in the expression of these marker genes ranged from moderately
reduced to faint residual staining (see Figs. 6 and 7). These
effects on Nkx2.5 and globin expression by A-MO were dose-
dependent, and injection of 5 ng/blastomere of A-MO decreased
the percentage of affected embryos in both cases to 64% and
44%, respectively (Table 1).
ADMP2 and heart development
The Xenopus heart undergoes extensive morphogenesis
during the tailbud stage (Mohun et al., 2000). We have
investigated the effect of ADMP2 knockdown on heart
formation at stage 32 because at this stage the myocardium
has formed a tube in all but the most anterior region (Mohun et
al., 2000). Nkx2.5 was used as a specific marker for heart at this
stage (Figs. 6A through F) (Tonissen et al., 1994). In transverse
sections of control embryos through the posterior heart, Nkx2.5
expression was observed in the tube of the myocardium (Fig.
6D, white arrowhead), and the pericardial roof (Fig. 6D, black
arrowheads). The pericardial cavities lateral to the tube can be
also recognized (Fig. 6D, arrow). In A-MO-injected embryos,
however, the staining for Nkx2.5 was faint, and it appeared as
though the heart tube had not formed (Figs. 6B and E). The
effect of A-MO on heart formation was specifically due to
Fig. 5. (A) Inhibition of translation by an ADMP2 antisense morpholino oligonucleotide. Western blot of proteins extracted from stage 14 embryos that have been
injected separately with 100 pg of RNA encoding an ADMP2/GFP fusion protein and either 10 ng of a control (c-MO) or antisense ADMP2 morpholino
oligonucleotide (A-MO). Shown is the result of immunoblotting using an anti-GFP antibody and an anti-alpha-tubulin antibody (loading control). (B–G) Loss-of-
function analysis of ADMP2. Control embryos (B, C, D), and embryos (E, F, G) injected with an antisense ADMP2 morpholino oligonucleotide (A-MO) probed for
expression of a somite marker, XmyoD (B, E), a pronephros marker, Xlim1 (C, F) or a lateral plate marker, Xnr1 (D, G). (B, E) Stage 14 embryos. Anterior is to the left.
Dorsal views. (C, D, F, G) Stage 24 embryos. Lateral views. Anterior to the left.
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version of ADMP2 RNA (ADMP2 Δ-5′ UTR) devoid of its 5′
UTR rescued the phenotype caused by injection of A-MO (Figs.
6C and F; Table 2). The amount of ADMP2 Δ-5′ UTR RNA
injected in this rescue experiment (5 pg×2) did not cause anyTable 1
Antisense ADMP2 morpholino oligonucleotide
Markers Uninjected c-MO
(5 ng)
c-MO
(10 ng)
A-MO
(5 ng)
A-MO
(10 ng)
Globin (P) – 90%
(n=21)
85%
(n=20)
56%
(n=102)
6.9%
(n=29)
Globin (A) – 100%
(n=23)
100%
(n=23)
84%
(n=51)
43%
(n=14)
SCL (P) – – 85%
(n=26)
– 28% (n=47)
Nkx2.5 (A) – 100%
(n=23)
86%
(n=22)
36%
(n=93)
3.3%
(n=30)
TnIC (A) – 94%
(n=16)
– 18%
(n=33)
Xlim1 (P) 100%
(n=13)
– – – 92%
(n=13)
Xnr1 (P) 86%
(n=50)
– – – 80%
(n=44)
MyoD (P) 100%
(n=13)
– – – 100%
(n=10)
Endodermin (P) 100%
(n=36)
– – – 100%
(n=30)
Results are reported as the percentage of embryos showing an expression of the
particular gene that is indistinguishable from the previously published pattern.
A-MO: antisense ADMP2 morpholino oligonucleotide; c-MO: control mor-
pholino oligonucleotide. P: posterior injection, A: anterior injection.phenotypes when injected alone (data not shown). The
expression of a myocardium specific marker, TnIc (Drysdale
et al., 1994), was also reduced at this stage (Fig. 6H compared to
G; Table 1). The hearts in A-MO-injected embryos at stage 46
were much smaller than those of control embryos, although they
could beat (data not shown). These results suggest that ADMP2
plays a role in specifying the heart.
ADMP2 and ventral blood island development
The VBIs form along the anterior/posterior axis of the belly
of the Xenopus larvae. Injection of the A-MO either anteriorly
or posteriorly resulted in a corresponding localized reduction in
the level of αT3 globin expression at stage 32 (Figs. 7A through
F and Figs. 7I through K). While 5 ng/blastomere of A-MO was
sufficient to disrupt globin posteriorly, disruption of anterior
globin expression was only observed at 10 ng/blastomere (Table
1; Figs. 7A, B, and D through F). The reason for this difference
is not clear, particularly since 5 ng/blastomere A-MO injected
anteriorly disrupted expression of heart markers (Table 1). The
effect of A-MO on VBI development was specifically due to the
knockdown of ADMP2 as co-injection of ADMP2 Δ-5′ UTR
RNA with A-MO rescued globin expression (Figs. 7C and K,
arrowheads; Table 2). The amount of ADMP2 Δ-5′ UTR RNA
injected in this rescue experiment (10 pg×2) did not alter
morphology when injected alone (data not shown).
αT3 globin is a terminal differentiation marker for the
primitive erythroid lineage, and the disruption of its expression
by A-MO might indicate a requirement for ADMP2 for certain
blood cell lineages only. However, we observed that expression
Fig. 6. Loss of ADMP2 and heart formation. (A and B) Injection of 10 ng of an antisense ADMP2 morpholino oligonucleotide into each of the two anterior
blastomeres of a 4-cell stage embryo inhibited the expression of the heart marker Nkx2.5 (c-MO: control morpholino; A-MO: antisense ADMP2 morpholino). (C)
This effect was reversed by co-injection of 5 pg of ADMP2 Δ-5′ UTR RNA (total 10 pg) (black arrowheads). (D) Transverse sections of c-MO-injected embryos
showed that Nkx2.5 was expressed in a tube of myocardium (white arrowheads) as well as the pericardial roof (black arrowheads in panel D). (E) A-MO-injected
embryos, on the other hand, showed only faint expression of Nkx2.5 (white arrowhead in panel E), and the heart tube was not formed. (F) Rescue of the A-MO
phenotype, as in panel C. (G, H) Anterior injection of 10 ng A-MO also reduced the expression of TnIC, another heart marker (black arrowhead in panel K
compared to that in panel J) (82%; Table 1).
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hematopoietic stem cells (Mead et al., 1998; Davidson and Zon,
2000), was reduced by A-MO at stage 24 (Fig. 7H compared to
G). Thus the entire primitive hematopoietic lineage appears to
be disrupted by injection of A-MO.
While the inhibition of globin expression by A-MO was
consistently observed, faint expression of globin persisted even
at the higher level of injected A-MO in many embryos (for
example, Fig. 7B). In a transverse section of an A-MO-injected
embryo at the level of the posterior VBIs, globin was observed
in a thin layer just underneath the ventral ectoderm (Figs. 7J and
L), while globin expression in c-MO-injected embryos extended
deeper into the mesodermal layer (Figs. 7I and L). The most
likely explanations for the persistence of low level globin
expression in A-MO-injected embryos are that the A-MO may
not be completely effective in inhibiting ADMP2 translation
(see Fig. 5), or that some blood is induced by an ADMP2-
independent pathway.
ADMP2 and BMP signaling in blood induciton
BMP signaling and its modulation are essential for many
processes in early vertebrate development, and alterations of
BMP signaling, either by overexpression or loss of function,
result in profoundly abnormal development (Dale et al., 1992;
Jones et al., 1992; Graff et al., 1994; Suzuki et al., 1994). For the
development of the VBIs, ectodermally derived BMP signaling
is proposed to induce primitive blood in the underlying
mesoderm (Maeno et al., 1994b; Kumano et al., 1999; Kikkawa
et al., 2001; Walmsley et al., 2002; Walters et al., 2002). The
fact that the A-MO-injected embryos appeared normal, with the
exception of ventral mesoderm derivatives, indicates that thereis no widespread disruption of BMP signaling. Nevertheless, we
investigated whether exogenous BMP7 would be able to rescue
VBI development in ADMP2 depleted embryo. Because BMP
overexpression causes a widespread disruption of development,
we first tested a low dose of BMP7 that does not give a strong
phenotype. At this dose of BMP7 (20 pg RNA), no elevation or
rescue of globin expression was observed (data not shown). We
next tested a second and higher dose of injected BMP7 RNA
(1 ng RNA). Injection of 1 ng of BMP7 RNA alone into
embryos resulted in embryos with a typical DAI 0 phenotype
and high levels of globin expression in the descendents of the
leading edge mesoderm (Fig. 7N). However, embryos coin-
jected with the A-MO and 1 ng BMP7 RNA had greatly reduced
levels of globin expression (10/16) relative to the embryos
injected with BMP7 alone, although the embryos still had DAI
0 phenotypes (Fig. 7M).
Discussion
ADMP2 was isolated from a library that was enriched for
genes induced in Xenopus animal caps by the mesoderm
inducer Xnr2 in the presence of XFD (Kumano and Smith,
2002a). The rationale for this screen is that in animal caps
injected with Xnr2 alone, dorsal mesoderm is predominantly
induced, while coinjecton of XFD to inhibit endogenous FGF
signaling results in the strong induction of ventral mesoderm in
the absence of dorsal mesoderm (Kumano et al., 2001). We
reasoned that genes induced in animal caps by the combination
of XFD and Xnr2 would likely be expressed in the presumptive
ventral mesoderm, and analysis of their function may provide
new clues to understanding the pathway of ventral mesoderm
induction.
Table 2
Rescue of A-MO-injected embryos
Markers Uninjected A-MO-injected A-MO/ADMP2-Δ-
5′UTR co-injected
Globin (P) 96% (n=26) 9.1% (n=33) 77% (n=31)
Nkx2.5 (A) 100% (n=29) 26% (n=39) 73% (n=37)
Embryos were injected with 10 ng/blastomere of A-MO either with or without
coinjected ADMP2 Δ-5′UTR RNA (5 pg RNA for anterior injection and 10 pg
for posterior injection). Results are reported as the percentage of embryos
showing an expression of the particular gene that is indistinguishable from the
previously published pattern. A-MO: antisense ADMP2 morpholino oligonu-
cleotide. P: posterior injection, A: anterior injection.
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ADMP2 is most closely related to ADMP by sequence and
overexpression phenotype. However, the two genes are clearly
distinguished by their expression patterns. ADMP is expressed
in the Spemann organizer during gastrulation, and subsequentlyFig. 7. ADMP2 loss and blood formation. (A and B) Posterior injection of 10 ng o
posterior blastomeres at the four cell stage inhibited the expression of globin in the
10 pg of ADMP2 Δ-5′ UTR RNA (total 20 pg) with A-MO restored globin expres
A-MO.While the 5 ng dose inhibited globin expression when injected posteriorly (E)
reduction in globin expression anteriorly was observed. (G and H) The expression o
posteriorly when examined at stage 24. (I and J) Transverse sections at the level of the
layer in the A-MO-injected embryos (black arrowhead in panel J compared to that in
the globin-expression extended deep into the mesodermal layer. (L) Enlarged view
injected embryos. (M, N) Coinjection of 10 ng A-MO into each blastomere at four ce
embryo). Note that both control (M) and A-MO-injected embryos (N) have the samin the axial mesoderm of neurula stage embryos (Moos et al.,
1995; Dosch and Niehrs, 2000). In contrast, ADMP2 is
expressed during early- and mid-gastrulation in a swath of
cells which extend from surface of the marginal zone towards
the blastocoel floor. The assignment of precise fates to the
ADMP2-expressing cells in the gastrulating embryo is not
simple. The ADMP2 expression domain is distinct from the
Xbra-expression domain, with ADMP2-expressing cells found
both vegetally and deeper than the Xbra-expressing cells. We
have previously shown that cells which express Xbra during the
gastrula stage do not populate the belly of the tadpole, but rather
end up exclusively in the dorsal mesoderm (Kumano et al.,
2001). Studies that have examined mesoderm migration and
fate in deep layers of the gastrulating embryo have described
leading edge mesoderm at mid-gastrulation as extending up in a
wedge from the surface to the blastocoel floor, a pattern similar
to that reported here for ADMP2 expression (see: Fig. 5F,
Keller, 1991; and Fig. 10 of Ibrahim and Winklbauer, 2001).
However, the reports differ on the pre-gastrula origin of the cellsf antisense ADMP2 morpholino oligonucleotide (A-MO) into each of the two
posterior ventral blood islands (c-MO: control morpholino). (C) Co-injection of
sion (white arrowhead). (D–F) Anterior injection of 5 and 10 ng/blastomere of
, no reduction in globin was observed at this dose anteriorly. At 10 ng (F) a strong
f SCL, an early blood marker, was also reduced by injection of 10 ng of A-MO
posterior blood islands show that the expression of globin was decreased to a thin
panel I). (K) In embryos co-injected with A-MO and ADMP2 Δ-5′ UTR RNA,
of ventral mid-line showing globin expression in either c-MO (left) or A-MO-
ll stage reduced globin expression in response to BMP7 RNA injection (1 ng per
e DAI 0 phenotype.
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the vegetal marginal zone, and Ibrahim et al. placing their origin
at the blastocoel floor. In either case, the mid-gastrula
expression domain of ADMP2 appears to include presumptive
ventral, but not dorsal mesoderm. However, the ADMP2
expression domain in the gastrulating embryo extends very
deep, and includes endodermal precursors. Further analysis of
the fates of ADMP2-expressing cells, particularly with a
promoter reporter construct as was done for Xbra (Kumano et
al., 2001), may help shed new light on the origin and induction
of ventral mesoderm.
ADMP2 is essential for ventral mesoderm development
Heart formation
Injection of morpholino oligonucleotides against ADMP2
disrupted heart development and inhibited the expression of the
heart markers Nkx2.5 and TnIc at stage 32. The development of
the heart in Xenopus is a complex process involving inductions
from neighboring tissues. It appears that wnt antagonists from
the Spemann organizer followed by signals from cerberus-
expressing endoderm cells (Schneider and Mercola, 1999)
during gastrulation initiate Nkx2.5 expression (Schneider and
Mercola, 2001). Tissue isolation experiments demonstrate that
signaling from the Spemann organizer is largely complete by
stage 10, while the endodermal signals remain active even after
stage 10.5 (Nascone and Mercola, 1995). The expression of
Nkx2.5 is then maintained, but not initiated, by BMP signaling
(Shi et al., 2000; Walters et al., 2001). Since ADMP2 is
expressed neither in the Spemann organizer region nor in
cerberus-expressing endoderm cells during gastrulation, it is
unlikely that this gene acts as an initiator of Nkx2.5 expression.
Instead, it is more likely that ADMP2 is necessary for
specification of the heart at a later stage within the leading
edge mesoderm. As both the heart and the VBIs are from this
mesoderm and both are affected by morpholino injection,
ADMP2 may play a role in specifying this entire region of
mesoderm, from which the heart is subsequently derived.
VBI formation
Injection of antisense morpholinos to ADMP2 inhibited the
expression of VBI markers SCL at stage 24, and globin at stage
32. This effect is not due to a loss of presumptive ventral
mesoderm, nor to a failure of the cells to migrate to their proper
location. Rather, ADMP2 more likely contributes directly to
blood induction. The inductive factors most strongly associated
with VBI induction are the BMPs (Dale et al., 1992; Jones et al.,
1992; Graff et al., 1994; Maeno et al., 1994a,b, 1996; Zhang and
Evans, 1996; Huber et al., 1998; Kumano et al., 1999;
Walmsley et al., 2002). Early models of mesoderm patterning
proposed that gastrula stage BMP signaling was sufficient for
VBI induction, and that genes downstream of gastrula BMP
signaling, such as Xvent 1, were in the pathway of VBI
induction (Huber and Zon, 1998; Davidson and Zon, 2000).
Furthermore, the blood inducing activity of BMP has been
taken as evidence in favor of the Spemann organizer model of
mesoderm patterning because the region of the gastrula mar-ginal zone with the highest level of BMP expression, the pole of
the marginal zone opposite the Spemann organizer, was thought
to correspond exactly to location of presumptive primitive
blood cells. However, further analysis has shown that blood
cells originate from a much broader region of the marginal zone,
including domains with very low BMP expression at gastrula-
tion (Tracey et al., 1998; Lane and Smith, 1999; Mills et al.,
1999; Ciau-Uitz et al., 2000). This apparent paradox in the BMP
requirement for blood induction appears to be explained by
observations that the induction of primitive blood may not occur
until the end of gastrulation when ventral mesoderm meets up
with BMP-producing ectoderm. It is proposed to be this
ectodermally derived BMP that is essential for primitive blood
induction, not the gastrula stage BMP within the marginal zone
(Maeno et al., 1994a,b; Kumano et al., 1999; Kikkawa et al.,
2001; Walmsley et al., 2002; Walters et al., 2002).
A two-step model for the induction of the VBIs has been
proposed (Kumano et al., 1999; Kikkawa et al., 2001; Kumano
and Smith, 2002b; Walmsley et al., 2002). In the first step,
presumptive ventral mesoderm is induced by general mesoder-
mal inducers. In the second step, BMP signaling from ectoderm
at late gastrulation induces the ventral-most mesoderm to
differentiate as VBI. Previously we have shown that the leading
edge mesoderm is uniquely able to respond to BMP signaling to
differentiate as VBI. For example, when BMP is overexpressed,
the total amount of globin increases, yet globin expression
remains restricted to the leading edge mesoderm (Fig. 7O;
Kumano and Smith, 2000). FGF appears to play a role in
defining domains within the mesoderm that have differential
competence to respond to primitive blood inducers. For
example, inhibition of FGF signaling leads to widespread
globin expression in the mesoderm-forming marginal zone
(Kumano and Smith, 2000). Nevertheless, the expansion of the
blood forming territory by FGF inhibition remains BMP
dependent, consistent with the two-step model. We have
shown here that loss of globin expression in embryos injected
with an ADMP2 antisense morpholino oligonucleotide cannot
be rescued by BMP, suggesting that ADMP2 is involved with
the first step in VBI induction, and that, in the absence of
ADMP2, presumptive ventral mesoderm is not competent to be
induced to primitive blood.
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